Further analysis by the researchers through assays such as western blot and GSEA revealed that TMEM100 regulated the TGF-beta pathway, and this regulation suppressed CRC cell growth by repressing TGF-β signaling pathway activation [29]. The gene discussed is TMEM100; the disease is colorectal carcinoma.